170. Occipital horn syndrome
[
1 clinical trial,
3 drugs（DrugBank:
3 drugs),
0 target gene / 0 target pathway ]
Searched query = "Occipital horn syndrome"
The queries were searched in Public_title, Scientific_title, and Condition of the data. Export date: 11/20/2019. Trials are sorted by Date_enrolment from most recent to oldest in the table.
| No. | TrialID | Date_ enrollement | Last_Refreshed_ on | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00811785 | February 27, 2009 | 26 August 2019 | Molecular Bases of Response to Copper Treatment in Menkes Disease, Related Phenotypes, and Unexplained Copper Deficiency | Molecular Bases of Response to Copper Treatment in Menkes Disease, Related Phenotypes, and Unexplained Copper Deficiency | Menkes Disease;Occipital Horn Syndrome;Unexplained Copper Deficiency | Drug: Copper Histidine | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | National Center for Complementary and Integrative Health (NCCIH) | Not recruiting | N/A | 80 Years | All | 93 | Phase 3 | United States |